ES2452034T5 - Composición para el cuidado de prótesis dental - Google Patents

Composición para el cuidado de prótesis dental Download PDF

Info

Publication number
ES2452034T5
ES2452034T5 ES07841570.0T ES07841570T ES2452034T5 ES 2452034 T5 ES2452034 T5 ES 2452034T5 ES 07841570 T ES07841570 T ES 07841570T ES 2452034 T5 ES2452034 T5 ES 2452034T5
Authority
ES
Spain
Prior art keywords
composition
dental prosthesis
prosthesis care
care
dental
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07841570.0T
Other languages
English (en)
Other versions
ES2452034T3 (es
Inventor
Charles V. Dullea
Stanley J. Lech
Fang Deng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
GlaxoSmithKline LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39136856&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2452034(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by GlaxoSmithKline LLC filed Critical GlaxoSmithKline LLC
Publication of ES2452034T3 publication Critical patent/ES2452034T3/es
Application granted granted Critical
Publication of ES2452034T5 publication Critical patent/ES2452034T5/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8135—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an acyloxy radical of a saturated carboxylic acid, of carbonic acid or of a haloformic acid; Compositions of derivatives of such polymers, e.g. vinyl esters (polyvinylacetate)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8176—Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8182—Copolymers of vinyl-pyrrolidones. Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A61Q11/02—Preparations for deodorising, bleaching or disinfecting dentures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Dental Preparations (AREA)

Description

imagen1
imagen2
imagen3
imagen4
imagen5
La descripción anterior describe completamente la invención incluidas realizaciones preferentes de la misma. Las modificaciones y mejoras de las realizaciones descritas en el presente documento específicamente están dentro del alcance de las reivindicaciones siguientes. Se cree que, sin más elaboración, un experto en la técnica, dada la descripción precedente, puede utilizar en su totalidad la presente invención. Por tanto, cualesquier ejemplos han de interpretarse como meramente ilustrativos y de ninguna forma son limitativos del ámbito de la presente invención. Las realizaciones de la invención en las que se reivindica una propiedad o privilegio exclusivos se definen como sigue.
7

Claims (1)

  1. imagen1
ES07841570.0T 2006-09-01 2007-08-30 Composición para el cuidado de prótesis dental Active ES2452034T5 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84220206P 2006-09-01 2006-09-01
US842202P 2006-09-01
PCT/US2007/077167 WO2008028003A2 (en) 2006-09-01 2007-08-30 Denture care composition

Publications (2)

Publication Number Publication Date
ES2452034T3 ES2452034T3 (es) 2014-03-31
ES2452034T5 true ES2452034T5 (es) 2017-09-18

Family

ID=39136856

Family Applications (1)

Application Number Title Priority Date Filing Date
ES07841570.0T Active ES2452034T5 (es) 2006-09-01 2007-08-30 Composición para el cuidado de prótesis dental

Country Status (12)

Country Link
US (2) US20090257961A1 (es)
EP (1) EP2056787B2 (es)
JP (1) JP2010502647A (es)
CN (1) CN101511988B (es)
AU (1) AU2007289171A1 (es)
BR (1) BRPI0714868A2 (es)
CA (1) CA2667755A1 (es)
ES (1) ES2452034T5 (es)
MX (1) MX2009002261A (es)
PL (1) PL2056787T5 (es)
RU (1) RU2009111866A (es)
WO (1) WO2008028003A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8623388B2 (en) * 2009-10-29 2014-01-07 The Procter & Gamble Company Denture care composition
US10064802B2 (en) 2013-09-11 2018-09-04 3M Innovative Properties Company Oral compositions, dental structures and methods of delivering oral compositions
CN105530998B (zh) 2013-09-11 2018-09-21 3M创新有限公司 口腔组合物
US8955528B1 (en) * 2013-12-20 2015-02-17 Guillermo Escobar Denture cleaning set
MX2019007098A (es) 2016-12-20 2019-09-05 Colgate Palmolive Co Composiciones para el cuidado bucal.
AU2017382566B2 (en) 2016-12-20 2020-03-12 Colgate-Palmolive Company Oral care composition
CN108379149A (zh) * 2018-04-10 2018-08-10 陈胜红 一种杀菌牙膏及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617744A1 (de) * 1964-07-24 1970-09-10 Peter Strong & Co Inc Reinigungsmittel fuer Zahnprothesen
GB1507356A (en) 1975-05-30 1978-04-12 Blendax Werke Schneider Co Denture cleanser
US4315779A (en) † 1979-10-01 1982-02-16 Richardson-Vicks Inc. Non-adhesive gel compositions for stabilizing dentures
US4511486A (en) * 1981-11-02 1985-04-16 Richardson-Vicks Inc. Method of cleaning dentures using aerated foams
GB8428523D0 (en) * 1984-11-12 1984-12-19 Ici Plc Oral hygiene composition
LU86596A1 (fr) * 1986-09-17 1988-04-05 Oreal Gel dentifrice
US5330746A (en) * 1988-05-03 1994-07-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Dental varnish composition, and method of use
JP2812496B2 (ja) * 1989-07-03 1998-10-22 サンスター株式会社 歯垢付着抑制洗口剤
EP0528756B1 (en) * 1991-08-19 1995-09-20 HAWE NEOS DENTAL Dr. H. V. WEISSENFLUH AG Tooth cleaning composition
MX9207168A (es) * 1991-12-10 1993-12-01 Dow Chemical Co Composiciones orales para inhibir la formacion de placa y de calculos.
US5891422A (en) * 1996-10-10 1999-04-06 Warner-Lambert Company Antimicrobial composition containing a C3 -C6 alcohol
US5855874A (en) * 1996-12-30 1999-01-05 Basf Corporation Dentifrice formulations containing liquid polyoxyalkylene compounds miscible in a liquid, polyalkylene glycol carrier
US6197331B1 (en) 1997-07-24 2001-03-06 Perio Products Ltd. Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity
JP2000014682A (ja) * 1998-06-30 2000-01-18 Lion Corp 義歯臭除去フィルム
WO2000017331A1 (en) * 1998-09-18 2000-03-30 Novozymes A/S A 2,6-β-D-FRUCTAN HYDROLASE ENZYME AND PROCESSES FOR USING THE ENZYME
JP2000327581A (ja) * 1999-05-19 2000-11-28 Higashimaru Shoyu Co Ltd 口腔殺菌用組成物
US8840918B2 (en) * 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US20040057908A1 (en) * 2001-12-13 2004-03-25 Bowen William H. Oral compositions and use thereof
US7025950B2 (en) * 2002-05-09 2006-04-11 The Procter & Gamble Company Oral care compositions comprising dicarboxy functionalized polyorganosiloxanes
MXPA05005153A (es) * 2002-11-14 2005-07-22 Smithkline Beecham Corp Dispositivo polimerico de disolucion controlada para la cavidad oral.
JP4756827B2 (ja) * 2004-03-31 2011-08-24 小林製薬株式会社 脱臭されたアクリレート／メタクリレート系三元共重合体及びその脱臭方法
US20060024246A1 (en) * 2004-07-29 2006-02-02 Prithwiraj Maitra Oral care compositions with film forming polymers
BRPI0514879A (pt) * 2004-09-02 2008-06-24 Procter & Gamble composição para tratamento bucal compreendendo óleos essenciais
AU2007281299A1 (en) † 2006-07-31 2008-02-07 Smithkline Beecham Corporation Denture adhesive composition

Also Published As

Publication number Publication date
ES2452034T3 (es) 2014-03-31
EP2056787A2 (en) 2009-05-13
WO2008028003A2 (en) 2008-03-06
RU2009111866A (ru) 2010-10-10
US20090257961A1 (en) 2009-10-15
CA2667755A1 (en) 2008-03-06
EP2056787A4 (en) 2013-01-02
WO2008028003A3 (en) 2008-12-31
PL2056787T5 (pl) 2017-10-31
PL2056787T3 (pl) 2014-06-30
EP2056787B2 (en) 2017-05-03
EP2056787B1 (en) 2014-01-22
MX2009002261A (es) 2009-03-20
CN101511988A (zh) 2009-08-19
JP2010502647A (ja) 2010-01-28
US20110217246A1 (en) 2011-09-08
BRPI0714868A2 (pt) 2013-05-28
AU2007289171A1 (en) 2008-03-06
CN101511988B (zh) 2014-04-02

Similar Documents

Publication Publication Date Title
ES2452034T5 (es) Composición para el cuidado de prótesis dental
CY1119596T1 (el) Σταθερη φαρμακευτικη συνθεση και μεθοδοι χρησης αυτης
CL2009000349A1 (es) Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer.
CY2014026I1 (el) Συνθεσεις και χρησεις για θεραπεια σκληρυνσης κατα πλακας
EA201100765A1 (ru) Наночастицы длительной циркуляции для замедленного высвобождения терапевтических средств
GT200900095A (es) Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hermatologicas.
CL2007002214A1 (es) Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
CL2007002327A1 (es) Compuestos derivados de fenil-imidazol sustituido; composicion farmaceutica; y uso en el tratamiento del vhc.
CL2008001076A1 (es) Compuestos derivados de sulfonamida; composicion farmaceutica; y uso en el tratamiento del cancer.
DOP2007000102A (es) Arilimidazolonas y ariltriazolona sustituidas asi como su uso
BR112012002124A2 (pt) tratamento da doença de crohn com laquinimode.
CL2012003026A1 (es) Composicion farmaceutica que comprende pioglitazona y linagliptina; procedimiento de preparacion; uso en el tratamiento de la diabetes tipo 2 o la obesidad.
DK2276485T3 (da) Anvendelse af epothilon d i behandling af tau-associerede sygdomme,herunder alzheimers sygdom
CO6440531A2 (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
CL2009000200A1 (es) Compuestos derivados de 2,7-naftiridinas-1-ona, mediadores de syk; composicion farmaceutica; y uso en el tratamiento de una enfermedad inflamatoria, respiratoria, proliferativa celular o autoinmune.
DE602006019838D1 (de) Piperazinsubstituierte benzothiophene zur behandlung von geisteskrankheiten
CL2007001993A1 (es) Compuestos derivados de pirimidilciclopentanos hidroxilados y metoxilados; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodegenerat
DOP2006000235A (es) Derivados de acidos dicarboxilicos y su uso
CL2009000119A1 (es) Compuestos derivados de amino-bencimidazoles sustituidos; composicion farmaceutica; y su uso en el tratamiento del alzheimer.
AR077125A1 (es) Combinaciones farmaceuticas utiles para tratar el vhc
BRPI0914410A2 (pt) composição de polidesoxirribonucleotídeo injetável para o tratamento de doenças osteoarticulares.
GT200900319A (es) (oxazolidinon-5-il-metil)-2-tiofen-carboxamidas sustituidas y su uso en el campo de la coagulación sanguínea
CY1115384T1 (el) Αντι-φλεγμονωδης συνθεση
CL2007003672A1 (es) Compuestos derivados de heteroaril-pirrolidinil-cetona y heteroaril-piperidinil-cetona; composicion farmaceutica; y uso en el tratamiento de la depresion y ansiedad.
CL2007002769A1 (es) Compuestos derivados de sulfonamida; procedimiento de obtencion; composicion farmaceutica; y uso en el tratamiento de la diabetes.